Raymond James & Associates Heron Therapeutics, Inc. Transaction History

Raymond James & Associates

$150 Billion
Q2 2024

A detailed history of Raymond James & Associates transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Raymond James & Associates holds 85,463 shares of HRTX stock, worth $162,379. This represents 0.0% of its overall portfolio holdings.

Number of Shares

85,463

Previous 87,520 2.35%

Holding current value

$162,379

Previous $242,000 23.55%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 19, 2024	SELL	$2.32 - $3.86 $4,772 - $7,940	-2,057 Reduced 2.35%	85,463 $299,000
Q1 2024 Apr 22, 2024	BUY	$1.71 - $3.06 $149,659 - $267,811	87,520 New	87,520 $242,000
Q4 2021 Feb 08, 2022	SELL	$8.35 - $12.6 $117,576 - $177,420	-14,081 Closed	0 $0
Q3 2021 Nov 02, 2021	BUY	$10.13 - $15.0 $142,640 - $211,215	14,081 New	14,081 $151,000
Q2 2021 Aug 11, 2021	SELL	$13.27 - $18.48 $607,606 - $846,162	-45,788 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$14.49 - $20.72 $524,885 - $750,561	36,224 Added 378.75%	45,788 $742,000
Q4 2020 Feb 12, 2021	BUY	$14.61 - $22.14 $139,730 - $211,746	9,564 New	9,564 $202,000
Q3 2020 Nov 04, 2020	SELL	$13.67 - $17.77 $159,720 - $207,624	-11,684 Closed	0 $0
Q2 2020 Jul 28, 2020	BUY	$10.89 - $21.47 $9,724 - $19,172	893 Added 8.28%	11,684 $172,000
Q1 2020 Apr 21, 2020	SELL	$10.23 - $24.56 $6,045 - $14,514	-591 Reduced 5.19%	10,791 $127,000
Q4 2019 Feb 12, 2020	SELL	$17.42 - $26.61 $60,273 - $92,070	-3,460 Reduced 23.31%	11,382 $267,000
Q3 2019 Nov 07, 2019	SELL	$16.36 - $21.39 $269,301 - $352,100	-16,461 Reduced 52.59%	14,842 $275,000
Q2 2019 Aug 06, 2019	BUY	$16.93 - $26.22 $109,164 - $169,066	6,448 Added 25.94%	31,303 $582,000
Q1 2019 May 06, 2019	BUY	$23.15 - $28.34 $28,937 - $35,425	1,250 Added 5.3%	24,855 $607,000
Q4 2018 Feb 11, 2019	SELL	$22.03 - $32.01 $55,559 - $80,729	-2,522 Reduced 9.65%	23,605 $612,000
Q3 2018 Nov 14, 2018	SELL	$30.0 - $40.85 $89,460 - $121,814	-2,982 Reduced 10.24%	26,127 $827,000
Q2 2018 Aug 14, 2018	BUY	$26.4 - $42.0 $4,356 - $6,930	165 Added 0.57%	29,109 $1.13 Million
Q1 2018 May 14, 2018	BUY	$18.43 - $28.8 $533,437 - $833,587	28,944 New	28,944 $799,000

Others Institutions Holding HRTX

# of Institutions

198

Shares Held

129M

Call Options Held

94.7K

Put Options Held

148K

View Full List

About HERON THERAPEUTICS, INC.

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $226M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

More about HRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Account

Raymond James & Associates Heron Therapeutics, Inc. Transaction History